PL
Plancorp LLC Portfolio holdings
AUM
$2.89B
This Quarter Return
-2.6%
1 Year Return
+13.99%
3 Year Return
+53.54%
5 Year Return
+86.93%
10 Year Return
+179.85%
AUM
$1.87B
AUM Growth
+$1.87B
(+0.78%)
Cap. Flow
+$64.2M
Cap. Flow
% of AUM
3.43%
Top 10 Holdings %
Top 10 Hldgs %
68.32%
Holding
264
New
22
Increased
154
Reduced
41
Closed
6
Top Buys
| 1 |
First Busey Corp
BUSE
|
$22.4M |
| 2 |
Vanguard Total Stock Market ETF
VTI
|
$13.5M |
| 3 |
Apple
AAPL
|
$3.68M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
$3.49M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
$3.48M |
Top Sells
| 1 |
Dimensional US Equity ETF
DFUS
|
$2.79M |
| 2 |
Dimensional US Core Equity 2 ETF
DFAC
|
$2.74M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
$1.7M |
| 4 |
Avantis Core Fixed Income ETF
AVIG
|
$892K |
| 5 |
Dimensional US Targeted Value ETF
DFAT
|
$570K |
Sector Composition
| 1 | Industrials | 2.99% |
| 2 | Financials | 2.42% |
| 3 | Technology | 2.3% |
| 4 | Healthcare | 1.77% |
| 5 | Consumer Staples | 1.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Dollar General
DG
$24.2B
| $766K | 0.04% |
7,241
+8
| +0.1% | +$846 |
|
127
Cigna
CI
$79.8B
| $726K | 0.04% |
2,539
-143
| -5% | -$40.9K |
|
128
Regeneron Pharmaceuticals
REGN
$61B
| $723K | 0.04% |
878
+11
| +1% | +$9.05K |
|
129
Automatic Data Processing
ADP
$121B
| $722K | 0.04% |
3,000
-119
| -4% | -$28.6K |
|
130
Vanguard Mid-Cap ETF
VO
$86.6B
| $722K | 0.04% |
3,465
| – | – |
|
131
Colgate-Palmolive
CL
$67.3B
| $719K | 0.04% |
10,109
+19
| +0.2% | +$1.35K |
|
132
Vanguard Total International Bond ETF
BNDX
$68B
| $713K | 0.04% |
14,911
+485
| +3% | +$23.2K |
|
133
Oracle
ORCL
$627B
| $711K | 0.04% |
6,709
+1,439
| +27% | +$152K |
|
134
iShares S&P 100 ETF
OEF
$22B
| $677K | 0.04% |
3,375
| – | – |
|
135
Amgen
AMGN
$153B
| $666K | 0.04% |
2,479
+16
| +0.6% | +$4.3K |
|
136
AT&T
T
$207B
| $666K | 0.04% |
44,309
+2,595
| +6% | +$39K |
|
137
Ameren
AEE
$26.9B
| $639K | 0.03% |
8,539
+1,059
| +14% | +$79.2K |
|
138
Elevance Health
ELV
$72.2B
| $639K | 0.03% |
1,467
+17
| +1% | +$7.4K |
|
139
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $614K | 0.03% |
12,315
+3,730
| +43% | +$186K |
|
140
iShares Core S&P Mid-Cap ETF
IJH
$99.3B
| $607K | 0.03% |
2,434
| – | – |
|
141
Shell
SHEL
$212B
| $574K | 0.03% |
8,910
+23
| +0.3% | +$1.48K |
|
142
DigitalOcean
DOCN
$2.91B
| $571K | 0.03% |
23,773
+5
| +0% | +$120 |
|
143
Vanguard Mega Cap Value ETF
MGV
$9.75B
| $564K | 0.03% |
5,562
| – | – |
|
144
Mondelez International
MDLZ
$78.9B
| $561K | 0.03% |
8,087
+117
| +1% | +$8.12K |
|
145
Philip Morris
PM
$252B
| $550K | 0.03% |
5,945
+446
| +8% | +$41.3K |
|
146
Bristol-Myers Squibb
BMY
$96.8B
| $548K | 0.03% |
9,449
+476
| +5% | +$27.6K |
|
147
Verizon
VZ
$183B
| $532K | 0.03% |
16,427
-1,347
| -8% | -$43.7K |
|
148
Texas Instruments
TXN
$177B
| $524K | 0.03% |
3,295
-33
| -1% | -$5.25K |
|
149
Ionis Pharmaceuticals
IONS
$9.7B
| $506K | 0.03% |
11,155
| – | – |
|
150
Novartis
NVS
$248B
| $487K | 0.03% |
4,777
+15
| +0.3% | +$1.53K |
|